The Science of Extracorporeal Ultrafiltration: Introducing a Novel Miniaturized Device

Cardiorenal medicine

article

Sgarabotto, Luca¹  Kazory, Amir⁴  Brendolan, Alessandra¹  Di Lullo, Luca⁵  Zanella, Monica¹  Ronco, Claudio¹ 

[1] International Renal Research Institute of Vicenza;Department of Nephrology, San Bortolo Hospital;Department of Medicine, University of Padova;Division of Nephrology, Hypertension, and Renal Transplantation, University of Florida;Department of Nephrology and Dialysis, L. Parodi – Delfino Hospital

关键词: Heart failure;    Cardiorenal syndrome;    Fluid overload;    Congestion;    Ultrafiltration;    Miniaturization;   

DOI  :  10.1159/000529613

学科分类：心脏病和心血管学

来源: S Karger AG

【 摘 要 】

Introduction: Fluid overload has been associated with untoward outcomes in a variety of clinical settings. Isolated extracorporeal ultrafiltration (UF) allows for mechanical extraction of excess fluid and optimization of volume status without the established risks associated with use of high-dose diuretics. Conventional machines for renal replacement therapy can be used to perform isolated UF. However, they typically need high blood flow rates with high circuit volumes and the therapy has to be performed by trained nurses. Herein, we describe a novel device, the Artificial Diuresis-1, or AD 1 (Medica S.p.A., Medolla, Italy), which is a portable technology designed to perform extracorporeal UF at bedside. Materials and Methods: The AD 1 uses a polysulfone mini-filter to generate ultrafiltrate with the help of two forces: blood flow (Qb) and gravity (based on the height at which the ultrafiltrate collection bag is placed). In vitro experiments were performed using human blood to evaluate vascular access pressures and ultrafiltrate volumes using various central venous catheters (CVCs; 12 Fr bilume, 10 Fr with 2 separate lumens, pediatric catheter 7 Fr). A variety of combinations were tested with Qb of 20, 35, 50 mL/min and collection bag height at 20, 40, 60 cm, measuring the UF rate per minute while monitoring the pressures in the venous and arterial lines and filtration fraction. Results: The device’s performance was as expected. Regarding the pediatric CVC, it was possible to perform measurements only with a Qb of 20 mL/min due to increased venous pressure. UF rates when lines were directly connected to the blood container as well as for CVC Tesio ranged from 3.7 to 11 mL/min, for the CVC Niagara™ from 4.5 to 12.5 mL/min, and for the CVC 7 Fr from 8.5 to 10 mL/min. The pressures of the vascular accesses were kept within a range of −5/-40 mm Hg for the artery and +10/+70 mm Hg for the vein. The highest venous pressure values were found with the CVC 7 Fr (+80/+100 mm Hg). Conclusions: This novel device allows to treat patients with fluid overload in a variety of settings, from low-intensity department such as long-term care facilities to the intensive care unit. The device is small and portable, has a simple design, and is user friendly. Future studies will be needed to evaluate whether gentle UF and treatment of volume overload will translate into improvement in clinical outcomes such as a reduction in congestion-related hospital admissions.

【 授权许可】

CC BY